Advisor Group Holdings, Inc. Atai Life Sciences N.V. Transaction History
Advisor Group Holdings, Inc.
- $44.4 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,292 shares of ATAI stock, worth $5,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,292
Previous 27,158
95.24%
Holding current value
$5,335
Previous $36,000
94.44%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ATAI
# of Institutions
111Shares Held
31.3MCall Options Held
506KPut Options Held
315K-
Ubs Group Ag7.7MShares$31.8 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$22.4 Million0.02% of portfolio
-
Morgan Stanley New York, NY3.49MShares$14.4 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$10.9 Million0.59% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$5.4 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $685M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...